Nutraceutical Excipients Market Size Projected to Reach $10.80 billion by 2034 | 7.6%

According to Straits Research, the global nutraceutical excipients market size was valued at $5.60 billion in 2025 and is projected to reach $10.80 billion by 2034, growing at a CAGR of 7.60% during the forecast period 2026–2034.

Market Dynamics

The nutraceutical excipients market is growing steadily due to the rise of clean-label supplements, sugar-reduced formulations, and innovative delivery formats such as gummies, shots, and delayed-release capsules. This shift is driven by consumer preference for products that balance health benefits with convenience and taste. Additionally, regulatory clarity, such as the FDA's updated guidance on dietary supplement ingredients in 2025, has strengthened the demand for high-quality, traceable excipients with proven safety and stability data. For instance, in April 2025, Ashland expanded its plant-based film coating line in Brazil to support clean-label tablets tailored for the North American and South American markets, highlighting the industry's adaptation to regional compliance and consumer trends.

However, the market also faces challenges. Rising scrutiny around nitrosamine contamination in cellulose-based excipients has led to tighter specifications and increased quality-control costs. Smaller supplement brands may struggle to adapt to these higher compliance standards, which can slow product launches and reformulations. Despite these hurdles, strong opportunities are emerging, especially in advanced dosage forms. For example, in 2025, Evonik’s launch of EUDRACAP colon-targeted capsules enabled the creation of next-generation gut-health supplements, supporting precision delivery and enhancing consumer trust. These developments signal a broader transition toward functional excipients that drive both product differentiation and long-term category growth.